1252 (1252) Fair Value & Analysis

Basic Materials · Market cap HK$740M

1 1252 1252 · HK

PriceHK$0.2400

Fair ValueHK$0.3624

Upside+51.0%

Quality51/100

Evidence: High Range HK$0.2730 – HK$0.4542

Fair value as of: Jul 2, 2026

From 22 valuation models · updated today

Price vs Fair Value (12 months)

12‑month range HK$0.1980 – HK$0.5300 · fair‑value band HK$0.2730 – HK$0.4542 · the HK$0.2400 price screens below the HK$0.3624 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1252 (1252) currently trades at HK$0.2400, while our model-based Fair Value estimate is HK$0.3624 — implying the stock looks roughly 51.0% undervalued today. We read business quality at 51/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 1252 generated revenue of HK$6.5B at a net margin of 5.0%. Revenue grew 14.7% year over year. It earns a return on equity of 1.6%. Net debt stands at HK$11.9B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$6.5B

Revenue growth (YoY) +14.7%

Net margin 5.0%

Return on equity 1.6%

Free cash flow HK$1.2B FY2024

P/E ratio 1.8

More key figures

Operating margin 8.6%

EPS (TTM) HK$0.0200

EPS growth (YoY) +149%

Net debt HK$11.9B FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

1252 reported revenue of HK$6.1B in FY2024 versus HK$12.2B in FY2020, a compound −15.8%/yr. Reported net income was HK$279M in FY2024, compounding −37.7%/yr from FY2020.

Revenue −15.8%/yr

FY20 HK$12.2B

FY21 HK$12.7B

FY22 HK$11.1B

FY23 HK$7.9B

FY24 HK$6.1B

Net income −37.7%/yr

FY20 HK$1.9B

FY21 HK$1.2B

FY22 HK$449M

FY23 −HK$634M

FY24 HK$279M

Is 1252 fairly valued? → Check now

Similar stocks

6 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
CRH plc CRH	$110.28	$70.25	-36%
Holcim AG HCMLY	$19.20	$8.68	-55%
Heidelberg Materials AG HEI	€190.80	€134.98	-29%
Vulcan Materials Company VMC	$299.09	$119.01	-60%
Martin Marietta Materials, Inc MLM	$575.83	$135.46	-76%
UltraTech Cement Limited ULTRACEMCO	₹10,866	₹4,589	-58%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1252 (1252) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.3624 versus a price of HK$0.2400 — about +51% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1252?

Our model-based fair value for 1252 is HK$0.3624 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2400.

What is the quality score of 1252?

1252 has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1252 (1252)?

1252 reported trailing-twelve-month revenue of about HK$6.5B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1252?

The net profit margin of 1252 is about 5.0%, meaning it keeps roughly 5.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.